Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin binding.

Molecular cell | Nov 25, 2003

The eukaryotic chaperonin TRiC/CCT mediates folding of an essential subset of newly synthesized proteins, including the tumor suppressor VHL. Here we show that chaperonin binding is specified by two short hydrophobic beta strands in VHL that, upon folding, become buried within the native structure. These TRiC binding determinants are disrupted by tumor-causing point mutations that interfere with chaperonin association and lead to misfolding. Strikingly, while unable to fold correctly in vivo, some of these VHL mutants can reach the native state when refolded in a chaperonin-independent manner. The specificity of TRiC/CCT for extended hydrophobic beta strands may help explain its role in folding aggregation-prone polypeptides. Our findings reveal a class of disease-causing mutations that inactivate protein function by disrupting chaperone-mediated folding in vivo.

Pubmed ID: 14636579 RIS Download

Mesh terms: Animals | Cattle | Cell Line | Chaperonins | HSP70 Heat-Shock Proteins | Humans | Intracellular Signaling Peptides and Proteins | Male | Microtubule-Associated Proteins | Models, Molecular | Neoplasms | Nuclear Proteins | Point Mutation | Protein Binding | Protein Folding | Protein Structure, Secondary | Protein Structure, Tertiary | Recombinant Fusion Proteins | Tumor Suppressor Proteins | Ubiquitin-Protein Ligases | Von Hippel-Lindau Tumor Suppressor Protein | t-Complex Genome Region

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, Id: GM56433

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.